The impact of a 1‐hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure von Krens, Stefanie D., Lubberman, Floor J. E., Egmond, Marthe, Jansman, Frank G. A., Burger, David M., Hamberg, Paul, Vervenne, Walter L., Gelderblom, Hans, Graaf, Winette T. A., Desar, Ingrid M. E., Herpen, Carla M. L., Erp, Nielka P.

Volltext

Intake and biomarkers of folate and folic acid as determinants of chemotherapy-induced toxicities in patients with colorectal cancer: a cohort study von Kok, Dieuwertje E, van Duijnhoven, Fränzel J B, Lubberman, Floor J E, McKay, Jill A, van Lanen, Anne-Sophie, Winkels, Renate M, Wesselink, Evertine, van Halteren, Henk K, de Wilt, Johannes H W, Ulrich, Cornelia M, Ulvik, Arve, Ueland, Per M, Kampman, Ellen

Volltext

Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review von Zwart, Nienke R.K., Franken, Mira D., Tissing, Wim J.E., Lubberman, Floor J.E., McKay, Jill A., Kampman, Ellen, Kok, Dieuwertje E.

Volltext

The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study) von Lubberman, Floor J.E., Gelderblom, Hans, Hamberg, Paul, Vervenne, Walter L., Mulder, Sasja F., Jansman, Frank G.A., Colbers, Angela, Graaf, Winette T.A., Burger, David M., Luelmo, Saskia, Moes, Dirk Jan A.R., van Herpen, Carla M.L., van Erp, Nielka P.

Volltext

Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors von Willemsen, Annelieke E.C.A.B., Lubberman, Floor J.E., Tol, Jolien, Gerritsen, Winald R., van Herpen, Carla M.L., van Erp, Nielka P.

Volltext

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics von Lubberman, Floor J. E., Benoist, Guillemette E., Gerritsen, Winald, Burger, David M., Mehra, Niven, Hamberg, Paul, van Oort, Inge, van Erp, Nielka P.

Volltext

Poorly specified fasting conditions in clinical research could lead to treatment failure von Lubberman, Floor J E, Burger, David, van Erp, Nielka P

Volltext

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal von Lubberman, Floor J E, van Erp, Nielka P, Ter Heine, Rob, van Herpen, Carla M L

Volltext

The effect of gastrectomy on regorafenib exposure and progression‐free survival in patients with advanced gastrointestinal stromal tumours von Lubberman, Floor J.E., Graaf, Winette T.A., Xu, Lei, Cleton, Adriaan, Demetri, George D., Gelderblom, Hans, Erp, Nielka P.

Volltext

Analytical challenges in quantifying abiraterone with LC–MS/MS in human plasma von Benoist, Guillemette E., Meulen, Eric, Lubberman, Floor J.E., Gerritsen, Winald R., Smilde, Tineke J., Schalken, Jack A., Beumer, Jan H., Burger, David M., Erp, Nielka P.

Volltext

Does a glass of Coke boost the exposure to imatinib in gastrointestinal stromal tumour patients after gastrectomy? von Lubberman, Floor J. E., Gelderblom, Hans, Wilmer, Carli M., Kweekel, Dina M., Desar, Ingrid M. E., Colbers, Angela, Burger, David, Graaf, Winette T. A., Erp, Nielka

Volltext

Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-base... von Renting, Lisanne, Zwart, Nienke R K, Ueland, Per Magne, McCann, Adrian, Ulvik, Arve, van Halteren, Henk K, Lubberman, Floor J E, Winkels, Renate M, Kampman, Ellen, Kok, Dieuwertje E

Volltext

Fasting conditions in clinical oncology trials and drug labelling – Authors' reply von Lubberman, Floor J E, Burger, David, van Erp, Nielka P

Volltext

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study von van der Kleij, Maud B A, Guchelaar, Niels A D, Meertens, Marinda, Westerdijk, Kim, Giraud, Eline L, Bleckman, Roos F, Groenland, Stefanie L, van Eerden, Ruben A G, Imholz, Alex L T, Vulink, Annelie J E, Otten, Hans-Martin, Fiebrich-Westra, Helle-Brit, Lubberman, Floor J E, Desar, Ingrid M E, Moes, Dirk-Jan A R, Touw, Daan J, Koolen, Stijn L W, Gelderblom, Hans, Reyners, An K L, van Erp, Nielka P, Mathijssen, Ron H J, Huitema, Alwin D R, Steeghs, Neeltje, Dutch Pharmacology Oncology Group (DPOG)

Volltext

Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal von Lubberman, Floor J E, van Erp, Nielka P, Ter Heine, Rob, van Herpen, Carla M L

Volltext